| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | $91.1M-52.6% | $192.4M-46.6% | $360.4M+85.2% | $194.6M+121.1% | $88.0M+1855.1% | $4.5M |
| Marketable securities | $700.0M+135.3% | $297.4M | $0 | — | — | — |
| Prepaid expenses and other current assets | $12.7M+241.3% | $3.7M-29.3% | $5.3M+36.1% | $3.9M+58.5% | $2.4M+335.6% | $562K |
| Total current assets | $803.9M+62.9% | $493.6M+35.0% | $365.7M+84.2% | $198.5M+119.4% | $90.5M+1686.5% | $5.1M |
| Property and equipment, net | $1.2M+54.3% | $751K+341.8% | $170K+1.2% | $168K+58.5% | $106K-63.9% | $294K |
| Right-of-use assets, operating leases | $1.1M-30.1% | $1.6M-18.7% | $1.9M+35.0% | $1.4M-12.9% | $1.6M | — |
| Other assets | $726K-13.4% | $838K+258.1% | $234K+101.7% | $116K-35.6% | $180K | — |
| Total assets | $806.9M+62.4% | $496.8M+35.0% | $368.0M+83.8% | $200.2M+116.6% | $92.4M+1010.8% | $8.3M |
| Accounts payable | $9.0M+13.5% | $7.9M-37.1% | $12.6M-21.9% | $16.2M+531.6% | $2.6M+7.7% | $2.4M |
| Accrued external research and development expenses | $11.5M+60.4% | $7.1M+259.6% | $2.0M | — | — | — |
| Other accrued expenses | $15.6M+92.2% | $8.1M+31.5% | $6.2M+0.8% | $6.1M+49.1% | $4.1M | — |
| Operating lease liabilities, current | $611K+370.0% | $130K-80.5% | $665K+116.6% | $307K-3.8% | $319K | — |
| Total current liabilities | $36.6M+57.1% | $23.3M+8.8% | $21.4M-5.0% | $22.6M+68.2% | $13.4M-46.0% | $24.9M |
| Long-term debt, net | $29.2M+3.0% | $28.3M | $0 | — | — | — |
| Operating lease liabilities, non-current | $1.3M-19.1% | $1.5M+7.8% | $1.4M+39.8% | $1.0M-23.0% | $1.3M | — |
| Total liabilities | $67.1M+26.1% | $53.2M+132.5% | $22.9M-3.1% | $23.6M+59.9% | $14.8M-51.1% | $30.2M |
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of December 31, 2025 and December 31, 2024 | $0 | $0 | $0 | $0 | — | $0 |
| Common stock, $0.0001 par value; 100,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 37,890,616 and 29,865,030 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $4K+33.3% | $3K+50.0% | $2K+0.0% | $2K | $0-100.0% | $2K |
| Additional paid-in capital | $1.25B+68.5% | $741.3M+38.9% | $533.8M+84.8% | $288.8M+24251.9% | $1.2M-98.7% | $91.0M |
| Accumulated other comprehensive income | $965K+233.9% | $289K | $0 | — | — | — |
| Accumulated deficit | -$510.2M-71.2% | -$298.0M-58.0% | -$188.6M-68.1% | -$112.2M-71.6% | -$65.4M+42.0% | -$112.8M |
| Total stockholders' equity | $739.8M+66.8% | $443.6M+28.5% | $345.1M+95.4% | $176.6M+375.1% | -$64.2M-193.7% | -$21.9M |
| Total liabilities and stockholders' equity | $806.9M+62.4% | $496.8M+35.0% | $368.0M+83.8% | $200.2M+116.6% | $92.4M+1010.8% | $8.3M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.